Literature DB >> 33440141

Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis.

Charles Arber1, Christopher Lovejoy2, Lachlan Harris3, Nanet Willumsen4, Argyro Alatza2, Jackie M Casey2, Georgie Lines2, Caoimhe Kerins2, Anika K Mueller2, Henrik Zetterberg5, John Hardy6, Natalie S Ryan6, Nick C Fox6, Tammaryn Lashley4, Selina Wray7.   

Abstract

Mutations in presenilin 1 (PSEN1) or presenilin 2 (PSEN2), the catalytic subunit of γ-secretase, cause familial Alzheimer's disease (fAD). We hypothesized that mutations in PSEN1 reduce Notch signaling and alter neurogenesis. Expression data from developmental and adult neurogenesis show relative enrichment of Notch and γ-secretase expression in stem cells, whereas expression of APP and β-secretase is enriched in neurons. We observe premature neurogenesis in fAD iPSCs harboring PSEN1 mutations using two orthogonal systems: cortical differentiation in 2D and cerebral organoid generation in 3D. This is partly driven by reduced Notch signaling. We extend these studies to adult hippocampal neurogenesis in mutation-confirmed postmortem tissue. fAD cases show mutation-specific effects and a trend toward reduced abundance of newborn neurons, supporting a premature aging phenotype. Altogether, these results support altered neurogenesis as a result of fAD mutations and suggest that neural stem cell biology is affected in aging and disease.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; NOTCH; PSEN1; hippocampus; iPSC; neurogenesis; organoid; γ-secretase

Mesh:

Substances:

Year:  2021        PMID: 33440141      PMCID: PMC7809623          DOI: 10.1016/j.celrep.2020.108615

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  16 in total

1.  Emerging Methods in Modeling Brain Development and Disease with Human Pluripotent Stem Cells.

Authors:  George E Allen; Aaron S Dhanda; Lisa M Julian
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Induced Pluripotent Stem Cell-Based Drug Screening by Use of Artificial Intelligence.

Authors:  Dai Kusumoto; Shinsuke Yuasa; Keiichi Fukuda
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-30

3.  Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer's Disease.

Authors:  Mehmet Ilyas Cosacak; Prabesh Bhattarai; Philip L De Jager; Vilas Menon; Giuseppe Tosto; Caghan Kizil
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

Review 4.  Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.

Authors:  Katrina Albert; Jonna Niskanen; Sara Kälvälä; Šárka Lehtonen
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

5.  Flexible and Accurate Substrate Processing with Distinct Presenilin/γ-Secretases in Human Cortical Neurons.

Authors:  Hirotaka Watanabe; Kent Imaizumi; Tetsuo Cai; Zhi Zhou; Taisuke Tomita; Hideyuki Okano
Journal:  eNeuro       Date:  2021-03-03

6.  Choroid plexus APP regulates adult brain proliferation and animal behavior.

Authors:  Karen Arnaud; Vanessa Oliveira Moreira; Jean Vincent; Glenn Dallerac; Chantal Dubreuil; Edmond Dupont; Max Richter; Ulrike C Müller; Laure Rondi-Reig; Alain Prochiantz; Ariel A Di Nardo
Journal:  Life Sci Alliance       Date:  2021-09-20

Review 7.  Knockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities.

Authors:  Rebecca M C Gabriele; Emily Abel; Nick C Fox; Selina Wray; Charles Arber
Journal:  Front Neurosci       Date:  2022-03-14       Impact factor: 4.677

Review 8.  The neurogenic niche in Alzheimer's disease.

Authors:  Connor M Wander; Juan Song
Journal:  Neurosci Lett       Date:  2021-07-13       Impact factor: 3.197

Review 9.  Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research.

Authors:  Feng-Chen Bi; Xin-He Yang; Xiao-Yu Cheng; Wen-Bin Deng; Xiao-Li Guo; Hui Yang; Yin Wang; Juan Li; Yao Yao
Journal:  Transl Neurodegener       Date:  2021-08-09       Impact factor: 8.014

Review 10.  Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease.

Authors:  Rajesh N Kalaria; Diego Sepulveda-Falla
Journal:  Am J Pathol       Date:  2021-07-28       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.